`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`
`
`DECLARATION OF HEINZ J. SALMEN
`IN SUPPORT OF MYLAN PHARMACEUTICALS INC.’S UNOPPOSED
`MOTION FOR PRO HAC VICE ADMISSION
`
`Mylan Exhibit 1096
`Mylan v. Regeneron, IPR2021-00881
`Page 1
`
`
`
`I, Heinz J. Salmen, declare as follows:
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`Declaration of Heinz J. Salmen
`
`
`1.
`
`I am an experienced litigating attorney with more than ten (10) years of
`
`experience.
`
`2.
`
`3.
`
`I have been actively litigating patent cases for more than ten (10) years.
`
`I am a member in good standing of the Illinois State Bar and admitted
`
`to practice in the United States Court of Appeals for the Federal Circuit and the
`
`United States District Court for the Northern District of Illinois.
`
`4.
`
`I have never been suspended or disbarred from practice before any court
`
`or administrative body.
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`6.
`
`I have had no sanctions or contempt citations imposed against me by
`
`any court or administrative body.
`
`7.
`
`I am familiar with the subject matter at issue in this proceeding. More
`
`specifically, I am familiar with the patent at issue in this proceeding—U.S. Patent
`
`No. 9,254,338 B2 (“the ’338 patent”). I am advising Mylan on patent matters
`
`relating to the subject matter claimed in the ’338 patent and have been involved in
`
`the strategy and drafting of Mylan’s Petition for Inter Partes Review of the ’338
`
`patent, including all prior art raised therein.
`
`
`
`1
`
`Mylan Exhibit 1096
`Mylan v. Regeneron, IPR2021-00881
`Page 2
`
`
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`Declaration of Heinz J. Salmen
`
`I have read and will comply with the Office Patent Trial Practice Guide
`
`8.
`
`and the Board’s Rules for Practice for Trials set forth in C.F.R. Part 42 – Trial
`
`Practice Before the Patent Trial and Appeal Board.
`
`9.
`
`I agree to be subject to the United States Patent and Trademark Office
`
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq., and to
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19.
`
`10.
`
`In the last three (3) years I have applied1 to appear pro hac vice in one
`
`(1) other IPR proceeding: Regeneron Pharmaceuticals, Inc. v. Novartis Vaccines
`
`and Diagnostics, Inc., IPR2019-01086, Paper 8 (June 16, 2019).
`
`11.
`
`I hereby declare that all statements made herein of my own knowledge
`
`are true and that all statements made on information and belief are believed to be
`
`true; and further that these statements are made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`pursuant to 18 U.S.C. § 1001.
`
`
`
`
`
`
`
`1 I note that I am concurrently seeking pro hac vice admission in Mylan
`
`Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc., IPR2021-00880
`
`(June 18, 2021).
`
`
`
`2
`
`Mylan Exhibit 1096
`Mylan v. Regeneron, IPR2021-00881
`Page 3
`
`
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`Declaration of Heinz J. Salmen
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Heinz J. Salmen/
`Heinz J. Salmen
`6 West Hubbard Street
`Suite 500
`Chicago, IL 60654
`Telephone:
`(312) 222-7504
`Facsimile:
`(312) 527-2157
`hsalmen@rmmslegal.com
`
`3
`
`Dated: June 18, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`Mylan Exhibit 1096
`Mylan v. Regeneron, IPR2021-00881
`Page 4
`
`